These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relation between duration of hypoprothrombinemia with dicumarol and the level of the drug in the liver. JAQUES LB; FROESE EL; O'TOOLE R; SPINKS JW Arch Int Pharmacodyn Ther; 1957 Sep; 111(4):478-89. PubMed ID: 13471097 [No Abstract] [Full Text] [Related]
5. [On a case of intestinal occlusion caused by hypoprothrombinemia in an aged patient]. Perrotin J; Prandi D Ann Chir; 1967 Nov; 21(23):1427-8. PubMed ID: 4185144 [No Abstract] [Full Text] [Related]
6. Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. Linder JD; Mönkemüller KE; Davis JV; Wilcox CM South Med J; 2000 Sep; 93(9):930-2. PubMed ID: 11005360 [TBL] [Abstract][Full Text] [Related]
7. Coagulopathy and hemorrhage associated with cefoperazone therapy in a patient with renal failure. Shenkenberg TD; Mackowiak PA; Smith JW South Med J; 1985 Apr; 78(4):488-9. PubMed ID: 3872479 [TBL] [Abstract][Full Text] [Related]
8. Lovastatin. Warfarin interaction. Ahmad S Arch Intern Med; 1990 Nov; 150(11):2407. PubMed ID: 2241455 [TBL] [Abstract][Full Text] [Related]
9. [Intramural hematomas of the small intestine in dicumarol treatment]. Härtel M Fortschr Geb Rontgenstr Nuklearmed; 1972 Sep; 117(3):306-11. PubMed ID: 4116515 [No Abstract] [Full Text] [Related]
10. Hypoprothrombinemia secondary to antibiotic therapy and manifested by massive gastrointestinal hemorrhage. Report of three codes. Klippel AP; Pitsinger B Arch Surg; 1968 Feb; 96(2):266-8. PubMed ID: 5317509 [No Abstract] [Full Text] [Related]
11. [Preventive effect of menaquinone-4 (K2) on hypoprothrombinemia caused by dicumarol]. Tajima T; Kawashima H; Kato Y; Ogo T; Miyao K Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):419-30. PubMed ID: 4107009 [No Abstract] [Full Text] [Related]
12. Dicumarol content in alcoholic herb elixirs: one of the factors at risk induced IVKD-I. Pansatiankul BJ; Mekmanee R Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():201-3. PubMed ID: 7533947 [TBL] [Abstract][Full Text] [Related]
13. Salicylate-induced hypoprothrombinemia. A report of four cases. Fausa O Acta Med Scand; 1970 Nov; 188(5):403-8. PubMed ID: 5490567 [No Abstract] [Full Text] [Related]
14. Moxalactam-induced hypoprothrombinemia with intrahepatic bleeding. Sylvester RK; Bailie GR; Kravitz GR; Smith TR Minn Med; 1984 Mar; 67(3):141-2. PubMed ID: 6738481 [No Abstract] [Full Text] [Related]
15. [Upper digestive hemorrhage of iatrogenic cause]. Saffiotti O; Mosca S; Di Cesare D; Esposito F Clin Ter; 1988 Jul; 126(1):49-53. PubMed ID: 2973959 [No Abstract] [Full Text] [Related]
16. [A case of acute cholestasis in treatment with dicumarol]. Dolinský A; Pavlík J Wien Med Wochenschr; 1968 Oct; 118(42):872-3. PubMed ID: 4179291 [No Abstract] [Full Text] [Related]
17. [Hemorrhagic complication caused by hypoprothrombinemia due to latamoxef]. Haramburu F; Conri C; Fleury B; Hervy G; Koch M Rev Med Interne; 1985 Jun; 6(3):329. PubMed ID: 4048694 [No Abstract] [Full Text] [Related]
18. Hypoprothrombinemia due to cefoperazone. Meisel S Drug Intell Clin Pharm; 1984 Apr; 18(4):316. PubMed ID: 6714079 [No Abstract] [Full Text] [Related]
19. Hypoprothrombinemia in patients receiving cefotetan. Foresti V; Guareschi G; Parisio E; Scolari N; Villa A Haematologica; 1990; 75(2):196. PubMed ID: 2358211 [No Abstract] [Full Text] [Related]
20. Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy. Gross L; Brotman M Ann Intern Med; 1970 Jan; 72(1):95-6. PubMed ID: 5410402 [No Abstract] [Full Text] [Related] [Next] [New Search]